T. Rowe Price Associates’s Crinetics Pharmaceuticals CRNX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $161M | Buy |
5,590,504
+478,144
| +9% | +$13.8M | 0.02% | 480 |
|
2025
Q1 | $171M | Sell |
5,112,360
-302,145
| -6% | -$10.1M | 0.02% | 455 |
|
2024
Q4 | $277M | Buy |
5,414,505
+469,748
| +9% | +$24M | 0.03% | 366 |
|
2024
Q3 | $253M | Buy |
4,944,757
+538,301
| +12% | +$27.5M | 0.03% | 391 |
|
2024
Q2 | $197M | Buy |
4,406,456
+583,238
| +15% | +$26.1M | 0.02% | 419 |
|
2024
Q1 | $179M | Buy |
3,823,218
+814,360
| +27% | +$38.1M | 0.02% | 442 |
|
2023
Q4 | $107M | Buy |
3,008,858
+430,659
| +17% | +$15.3M | 0.01% | 527 |
|
2023
Q3 | $76.7M | Buy |
2,578,199
+1,149,289
| +80% | +$34.2M | 0.01% | 562 |
|
2023
Q2 | $25.8M | Buy |
1,428,910
+1,387,127
| +3,320% | +$25M | ﹤0.01% | 868 |
|
2023
Q1 | $672K | Sell |
41,783
-10,148
| -20% | -$163K | ﹤0.01% | 1979 |
|
2022
Q4 | $951K | Sell |
51,931
-9,704
| -16% | -$178K | ﹤0.01% | 1796 |
|
2022
Q3 | $1.21M | Buy |
61,635
+7,228
| +13% | +$142K | ﹤0.01% | 1656 |
|
2022
Q2 | $1.02M | Buy |
54,407
+16,824
| +45% | +$314K | ﹤0.01% | 1887 |
|
2022
Q1 | $825K | Sell |
37,583
-39,239
| -51% | -$861K | ﹤0.01% | 2089 |
|
2021
Q4 | $2.18M | Buy |
76,822
+10,659
| +16% | +$303K | ﹤0.01% | 1680 |
|
2021
Q3 | $1.39M | Buy |
66,163
+238
| +0.4% | +$5.01K | ﹤0.01% | 1874 |
|
2021
Q2 | $1.24M | Buy |
65,925
+17,060
| +35% | +$322K | ﹤0.01% | 1968 |
|
2021
Q1 | $747K | Sell |
48,865
-32,037
| -40% | -$490K | ﹤0.01% | 2182 |
|
2020
Q4 | $1.14M | Sell |
80,902
-5,166
| -6% | -$72.9K | ﹤0.01% | 1877 |
|
2020
Q3 | $1.35M | Hold |
86,068
| – | – | ﹤0.01% | 1679 |
|
2020
Q2 | $1.51M | Buy |
86,068
+57,660
| +203% | +$1.01M | ﹤0.01% | 1626 |
|
2020
Q1 | $418K | Sell |
28,408
-7,700
| -21% | -$113K | ﹤0.01% | 2059 |
|
2019
Q4 | $906K | Sell |
36,108
-16,175
| -31% | -$406K | ﹤0.01% | 1924 |
|
2019
Q3 | $786K | Sell |
52,283
-435,633
| -89% | -$6.55M | ﹤0.01% | 1912 |
|
2019
Q2 | $12.2M | Buy |
487,916
+1,786
| +0.4% | +$44.7K | ﹤0.01% | 1281 |
|
2019
Q1 | $11.1M | Buy |
486,130
+52,134
| +12% | +$1.19M | ﹤0.01% | 1303 |
|
2018
Q4 | $13M | Buy |
433,996
+91
| +0% | +$2.73K | ﹤0.01% | 1262 |
|
2018
Q3 | $12.4M | Buy |
+433,905
| New | +$12.4M | ﹤0.01% | 1337 |
|